Hypothesis

Age‑dependent upregulation of ileal ASBT (SLC10A2) is not a passive decline but an actively maintained, sexually dimorphic program that maximizes early‑life reproductive fitness by enhancing bile‑acid‑dependent gut‑brain signaling, while inevitably driving late‑life neurodegeneration through a shifted bile‑acid pool that activates neuroinflammatory pathways.

Mechanistic Reasoning

1. Early‑life benefit – Elevated ASBT increases hepatic return of conjugated primary bile acids (CPBAs). CPBAs activate intestinal FXR, boosting FGF19 release, which suppresses hepatic CYP7A1 and tailors the bile‑acid pool toward hydrophilic species that efficiently solubilize dietary lipids and fat‑soluble vitamins. This improves maternal nutrient status and supports gonadal steroidogenesis, thereby increasing fecundity. Sex‑specific glucocorticoid amplification of ASBT in females aligns with heightened reproductive demand.[https://pmc.ncbi.nlm.nih.gov/articles/PMC11148718/]

2. Late‑life cost – Persistent ASBT expression continues to shunt CPBAs to the liver despite falling CYP7A1, causing hepatic FXR overstimulation and excessive FGF19. Chronic FGF19 signaling downregulates CYP7A1 beyond homeostatic levels, shifting the intrahepatic bile‑acid composition toward hydrophobic, cytotoxic species (e.g., deoxycholic acid). These acids enter circulation, cross the blood‑brain barrier, and activate microglial TGR5 and NLRP3 inflammasomes, provoking neuroinflammation and synaptic loss.[https://pubmed.ncbi.nlm.nih.gov/17537158/]

3. Sex specificity – Greater ASBT upregulation in females yields a higher burden of hydrophobic bile acids post‑menopause, mirroring the increased incidence of Alzheimer‑type pathology in women.

Testable Predictions

• Prediction 1: Conditional, ileal‑specific ASBT knockdown in 12‑month‑old mice (post‑pubertal, pre‑menopausal equivalent) will reduce serum CPBAs by ≥30 % and increase the hydrophilic/hydrophobic bile‑acid ratio without altering litter size or pup survival when compared to wild‑type controls.
• Prediction 2: The same intervention will lower hippocampal microglial IBA1 and NLRP3 expression by ≥25 % and improve performance in the Morris water maze (escape latency reduced by ≥15 %).
• Prediction 3: In female mice, ASBT knockdown will attenuate the age‑related rise in plasma ammonia and cognitive decline seen in ovariectomized models, whereas male mice will show a smaller but significant effect.

Experimental Approach

• Generate Villin‑CreERT2;ASBT^fl/fl mice for tamoxifen‑inducible ileal deletion.
• Administer tamoxifen at 10 weeks (to avoid developmental confounds) and assess reproductive output over two breeding cycles.
• At 12 months, collect serum, liver, ileum, and brain for bile‑acid profiling (LC‑MS), FGF19, CYP7A1, and neuroinflammatory markers.
• Conduct behavioral testing (novel object recognition, water maze) and histological analysis.

Potential Outcomes and Interpretation

• If predictions hold, the data support ASBT as an antagonistically pleiotropic node: its activity is advantageous early (enhanced nutrient absorption and reproductive success) but becomes deleterious later via bile‑acid‑mediated neuroinflammation.
• Failure to observe reproductive preservation despite metabolic benefit would refute the hypothesis and suggest that ASBT upregulation is merely a maladaptive stochastic drift.
• Demonstrating that cognitive rescue occurs without compromising early fitness would indicate that longevity interventions can negotiate with evolutionary logic rather than override it, aligning with the seed idea that aging may be a programmed, tunable trait.